| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $5.6M | -26.2% |
| SG&A Expense | $3.2M | +9.7% |
| Operating Income | -$8.8M | +16.2% |
| Income Tax | $800 | — |
| Net Income | -$8.4M | +20.1% |
| EPS (Basic) | -$0.61 | +26.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | -11.2% |
| Current Assets | $7.3M | -44.3% |
| Total Assets | $7.3M | -44.5% |
| Current Liabilities | $1.8M | -43.8% |
| Total Liabilities | $1.8M | -44.0% |
| Stockholders' Equity | $5.6M | -44.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.9M | -8.7% |
| Investing Cash Flow | $4.9M | +200.2% |
| Financing Cash Flow | $2.0M | +6066.8% |